| LCFLX | RWEBX | LCFLX / RWEBX | |
| Total Expense Ratio | 1.71 | 1.06 | 161% |
| Annual Report Gross Expense Ratio | 2.27 | 1.06 | 214% |
| Fund Existence | 7 years | 12 years | - |
| Gain YTD | 7.793 | 4.539 | 172% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1500 | 250 | 600% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 164M | 219B | 0% |
| Annual Yield % from dividends | 0.00 | 0.75 | - |
| Returns for 1 year | 15.27 | 6.15 | 248% |
| Returns for 3 years | 57.81 | 25.02 | 231% |
| Returns for 5 years | -9.21 | 24.77 | -37% |
| Returns for 10 years | N/A | 73.76 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FREIX | 37.40 | 0.23 | +0.62% |
| Franklin Equity Income R | |||
| JSJCX | 15.12 | 0.03 | +0.20% |
| JHancock Small Cap Dynamic Growth C | |||
| VIVAX | 85.80 | -0.25 | -0.29% |
| Vanguard Morn Value Index Investor | |||
| VSFRX | 28.70 | -0.10 | -0.35% |
| Federated Hermes MDT Small Cap Value R | |||
| PHLCX | 10.41 | -0.12 | -1.14% |
| PGIM Jennison Health Sciences C | |||